Top 3 Health Care Stocks You'll Regret Missing In Q3

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential investment opportunities in undervalued companies [1] Group 1: Oversold Stocks - Summit Therapeutics Inc (SMMT) has an RSI value of 22.4, with a stock price of $19.44 and a 52-week low of $15.55, having fallen approximately 31% over the past month [6] - Lunai Bioworks Inc (RENB) has an RSI value of 29.3, with a stock price of $0.19 and a 52-week low of $0.18, experiencing a decline of around 23% over the past five days [6] - CERo Therapeutics Holdings Inc (CERO) has an RSI value of 16.3, with a stock price of $4.68 and a 52-week low of $4.27, having dropped about 37% over the past five days [6]